News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Levothyroxine offers no cardiometabolic benefits in older adults with subclinical hypothyroidism
25 Sep 2026
byStephen Padilla
Treatment with levothyroxine does not yield clear effects on cardiometabolic biomarkers in older adults with subclinical hypothyroidism, according to a study. However, individuals with baseline thyroid-stimulating hormone (TSH) ≥10 mIU/L show potentially favourable changes in lipids and lipoproteins.








